Inventor · disambiguated record
Satoshi Nagata
Also filed as: NAGATA SATOSHI
9 granted patents·7 pending applications·195 citations·filing 1999–2023
89Inventor score
Files withUS HEALTH4MED & BIOLOGICAL LAB CO LTD3FOUNDATION FOR BIOMEDICAL RES AND INNOVATION AT KOBE2NAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION1NAT INSTITUTES OF BIOMEDICAL INOVATION HEALTH AND NUTRITON1
Top patents by PatentIndex Score
16 records- 0194US7521054B2Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the Fv to lower the isoelectric pointUS HEALTH·Filed 2001·Granted Apr 21, 2009·72 cites·8 claims
- 0289US7999077B2IRTA2 antibodies and methods of useUS HEALTH·Filed 2005·Granted Aug 16, 2011·23 cites·17 claims
- 0388US10925969B2Anti-BCMA polypeptides and proteinsUS HEALTH·Filed 2016·Granted Feb 23, 2021·6 cites·25 claims
- 0488US6709833B2Monoclonal antibody recognizing phosphatidylinositol-3,4-diphosphateYASUHISA FUKUI·Filed 2000·Granted Mar 23, 2004·51 cites·5 claims
- 0583US7470775B2Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxinsUS HEALTH·Filed 2003·Granted Dec 30, 2008·18 cites·37 claims
- 0682US8907060B2Mutated Pseudomonas exotoxins with reduced antigenicityPASTAN IRA H·Filed 2006·Granted Dec 9, 2014·6 cites·105 claims
- 0775US6818408B2Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphateMED & BIOLOGICAL LAB CO LTD·Filed 2001·Granted Nov 16, 2004·3 cites·4 claims
- 0855US6348580B1Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphateMED & BIOLOGICAL LAB CO LTD·Filed 1999·Granted Feb 19, 2002·16 cites·4 claims
- 0953US2005043514A1Monoclonal antibody recognizing phosphatidylinositol-3,4-diphosphateYASUHISA FUKUI AND MEDICAL & B·Filed 2003·Application pending·0 cites
- 1053US2025382371A1Antibody or fragment thereof that binds to fcrl1NAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION·Filed 2023·Application pending·0 cites
- 1153US2024317859A1Anti-human pd-1 agonist antibody and pharmaceutical composition comprising the antibody for treating or preventing inflammatory diseasesFOUNDATION FOR BIOMEDICAL RES AND INNOVATION AT KOBE·Filed 2022·Application pending·0 cites
- 1250US2023192877A1Epitope region-bridging biparatopic antibody and method for producing sameNAT INSTITUTES OF BIOMEDICAL INOVATION HEALTH AND NUTRITON·Filed 2021·Application pending·0 cites
- 1349US2024034787A1Optic nerve protecting agent containing anti-lrp1 antibodyTOKYO UNIV OF PHARMACY & LIFE SCIENCES·Filed 2021·Application pending·0 cites
- 1449US2023183347A1PD-1 Agonist-Containing Pharmaceutical Composition for Treating or PReventing TH2-Mediated DiseaseFOUNDATION FOR BIOMEDICAL RES AND INNOVATION AT KOBE·Filed 2021·Application pending·0 cites
- 1546US2004018203A1Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugatesFiled 2001·Application pending·0 cites
- 1631US7276375B2Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphateMED & BIOLOGICAL LAB CO LTD·Filed 2004·Granted Oct 2, 2007·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Satoshi Nagata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →